| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.015 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |